The clinical guidelines and policies have been developed in collaboration between SWL ICB medicines management team, secondary, community, and primary care, taking into consideration local, national, and international publications available at the time of preparation.
This webpage is kept under review and reflects the latest guidance at the time of publication. It is recognised that research in the world of diabetes is fast-moving, it remains the responsibility of prescribers to ensure they adhere to the latest guidelines, license changes, and product availability.
In addition to the guidelines, the following position statements are available: